Long term outcome of patients with hairy
β
Patricia Ribeiro; Fadhela Bouaffia; Pierre-Yves Peaud; Michel Blanc; Bruno Salle
π
Article
π
1999
π
John Wiley and Sons
π
English
β 107 KB
π 2 views
## BACKGROUND. With the introduction of new drugs such as interferon-β£ (IFN) and purine analogs, the management of hairy cell leukemia (HCL) patients has changed. However, pentostatin has been found to produce higher complete remission rates than IFN. The current study was undertaken to investigat